Valuentum’s President Brian Nelson talks about J&J’s (JNJ) solid dividend growth prospects and budding late stage pharma pipeline in the EU and US. January 20, 2015.
Exclusive Analysis for the Discerning Investor
Exclusive Analysis for the Discerning Investor
Valuentum’s President Brian Nelson talks about J&J’s (JNJ) solid dividend growth prospects and budding late stage pharma pipeline in the EU and US. January 20, 2015.